BRCA1-mutated basal-like breast cancer cells exhibited primary resistance to denosumab in mammosphere assays, thereby leading to an increased propensity in developing aggressive breast neoplasms and increasing the bone metastasis-initiation capacity of these cells [274]. This evidence concerns the gene BRCA1 and breast carcinoma.